DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis
Lars Tögel(Friedrich-Alexander-Universität Erlangen-Nürnberg), John M. Mariadason(Olivia Newton-John Cancer Wellness & Research Centre)
Cited by 19
Related Papers
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
|Oral Oncology|2012|91